TABLE 3

Secondary Outcome Measures and Differences Between Study Groups: χ2 Test

VariableLGG Group (n = 376)Placebo Group (n = 366)RR (95% CI)NNT (95% CI)
Vomiting episodes, n (%)17 (4.5)33 (9.0)0.50 (0.30–0.90)23 (13–110)
Diarrheal episodes, n (%)7 (1.9)28 (7.7)0.24 (0.10–0.50)18 (11–35)
Duration of gastrointestinal infection >2 d, n (%)a19 (5.1)45 (12.3)0.40 (0.25–0.70)14 (9–31)
Duration of respiratory infection >3 d, n (%)a8 (2.1)19 (5.2)0.40 (0.20–0.90)33 (17–257)
Duration of hospital intervention, median (interquartile range)db5 (3–7)4 (4–6)
  • a Number of infections over 2 to 3 days.

  • b Difference analyzed with Mann-Whitney U test.